News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Hope Rugo: Fabrice Andre presents DB07 at ASCO24
Photo from Hope Rugo/X
Jun 2, 2024, 23:39

Hope Rugo: Fabrice Andre presents DB07 at ASCO24

Hope Rugo, Medical hematologist-oncologist at UCSF, shared on X/Twitter:

“Fabrice Andre presents DB07. The expected amazing and durable response to first line TDXd +/- Pertuzumab. Adding P almost tripled grade 3 diarrhea rates; no grade 5 ILD. Imp implications for DB09 and great to see this efficacy.”

Image

Source: Hope Rugo/X

cancer Fabrice Andre grade 3 diarrhea rates Hope Rugo OncoDaily Oncology TDXd +/- Pertuzumab
Insight
Aug 11, 2024, 02:26
‘The Alabama Access Initiative’ by UAB O'Neal Comprehensive Cancer Center
Blog
Aug 11, 2024, 02:25
Representatives from Lung Cancer Europe at the ESMO 2024
Societies
Aug 11, 2024, 02:13
12 Posts Not To Miss From Day 3 of ASCOBT24!
Insight
Aug 11, 2024, 01:16
Angela Mastronuzzi: Machine Learning Analysis in Diffusion Kurtosis Imaging for Pediatric Posterior Fossa Tumors
Blog
Aug 10, 2024, 19:20
Sarah P. Psutka: Bolster brain health through treatment and survivorship
Societies
Aug 10, 2024, 19:12
Register for the SITC Immuno-oncology Drug Development Summit in Boston
Blog
Aug 10, 2024, 18:58
Amylou Dueck: Treat your biostatistician well
Positive
Aug 10, 2024, 18:45
Selwyn M. Vickers: Like our celebrated Olympians, the people of MSK show medal-worthy dedication
Insight
Aug 10, 2024, 18:35
Tony Collier: Webinar about the TRANSFORM trial for prostate cancer
Insight
Aug 10, 2024, 17:53
Stephen Liu: Biomarker results and the timing for lung cancer treatment
Drugs
Aug 10, 2024, 17:37
Michael Makris: The therapeutic landscape of ITP treatments is expanding rapidly
Blog
Aug 10, 2024, 17:20
Anthi Papouli: I had the pleasure to attend the GenAI in Healthcare event